Status: current, Sufficiently defined by necessary conditions definition status. Date: 30-Jun 2022. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5068897012 | Powder for conventional release suspension for endotracheopulmonary instillation | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
5068898019 | Powder for conventional release suspension for endotracheopulmonary instillation (dose form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
5068899010 | Powder for suspension for endotracheopulmonary instillation | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Powder for conventional release suspension for endotracheopulmonary instillation | Is a | Endotracheopulmonary dose form | true | Inferred relationship | Existential restriction modifier | ||
Powder for conventional release suspension for endotracheopulmonary instillation | Has basic dose form | Powder | true | Inferred relationship | Existential restriction modifier | ||
Powder for conventional release suspension for endotracheopulmonary instillation | Has dose form intended site | Endotracheopulmonary | true | Inferred relationship | Existential restriction modifier | ||
Powder for conventional release suspension for endotracheopulmonary instillation | Has dose form release characteristic | Conventional release | true | Inferred relationship | Existential restriction modifier | ||
Powder for conventional release suspension for endotracheopulmonary instillation | Has dose form transformation | Disperse | true | Inferred relationship | Existential restriction modifier | ||
Powder for conventional release suspension for endotracheopulmonary instillation | Has dose form administration method | Instill | true | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely colfosceril palmitate 108 milligram/1 vial powder for conventional release suspension for endotracheopulmonary instillation (clinical drug) | Has manufactured dose form | True | Powder for conventional release suspension for endotracheopulmonary instillation | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets